New York, Bronx, New York Clinical Trials

A listing of New York, Bronx, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 483 clinical trials
Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Primary Objectives: Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. Phase 2: To evaluate the efficacy of isatuximab in desensitization of patients awaiting kidney transplantation. Secondary Objectives: Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. To characterize the pharmacokinetic …

nephropathy
sar650984
isatuximab
diphenhydramine
chronic kidney disease
Investigational Site Number 8400002
 (9.0 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +2 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

line of therapy
bortezomib
immunotherapeutic agent
multiple myeloma
proteasome inhibitor
Investigational Site Number 8400001
 (5.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations
QA_Study Trial 01

Test Comment here

QA_Site01
 (10.0 away) Contact site
  • 0 views
  • 23 Jan, 2023
  • 1 location
sandeep Testing 11821 1  

test

Diabetes
 (10.0 away)
  • 0 views
  • 17 Apr, 2023
  • +2 other locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

James J. Peters VA Medical Center
 (2.4 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI test  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Accepts healthy volunteers
James J. Peters VA Medical Center
 (2.4 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations
Distal Peripheral Neuropathy in Type 2 Diabetes (DSP/DM)  

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency …

New York University, Division of Special Studies in Symptom Management
 (9.5 away)
  • 0 views
  • 26 Sep, 2022
  • +2 other locations
Berberine Supplementation, Sprint Interval Training, and Immune Function Study  

The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencing mild mental health challenges. The main questions …

Accepts healthy volunteers
New York Medical and Diagnostic Center
 (9.2 away)
  • 0 views
  • 07 Jul, 2026
  • +2 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

resting tremor
bradykinesia
datscan
muscle rigidity
modafinil
Columbia University Medical Center
 (4.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

eliglustat
gaucher disease
imiglucerase
deficiency
Investigational Site Number 840005
 (5.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +208 other locations